Catalog No.: PC-62053Not For Human Use, Lab Use Only.
FGI-106 is a broad-spectrum inhibitor of multiple blood-borne viruses (HCV, HBV, HIV) as well as emerging biothreats (Ebola, VEE, Cowpox, PRRSV infection) with EC50 of 0.2-10 uM.
FGI-106 is a broad-spectrum inhibitor of multiple blood-borne viruses (HCV,HBV, HIV) as well as emerging biothreats (Ebola, VEE, Cowpox, PRRSV infection) with EC50 of 0.2-10 uM.
FGI-106 inhibits the interaction of TSG101 with its cognate viral ligands.
FGI-106 displays an ability to prevent lethality from Ebola in vivo; well-tolerated and orally bioavailable.
